Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001013762-25-001846
Filing Date
2025-03-25
Accepted
2025-03-25 08:00:28
Documents
6
Period of Report
2025-03-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0235561-6k_alterity.htm 6-K 14210
2 CEASING TO BE A SUBSTANTIAL HOLDER ea023556101ex99-1_alterity.htm EX-99.1 10303
3 GRAPHIC ex99-1_001.jpg GRAPHIC 485043
4 GRAPHIC ex99-1_002.jpg GRAPHIC 360055
5 GRAPHIC ex99-1_003.jpg GRAPHIC 96425
6 GRAPHIC ex99-1_004.jpg GRAPHIC 541555
  Complete submission text file 0001013762-25-001846.txt   2067819
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 25765904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)